A meta-analysis of comparing EGFR-TKI with chemotherapy as the second-line treatment of NSCLC patients with wild-type EGFR.
Guanghui Gao
No relevant relationships to disclose
Shengxiang Ren
No relevant relationships to disclose
Aiwu Li
No relevant relationships to disclose
Yayi He
No relevant relationships to disclose
Xiaoxia Chen
No relevant relationships to disclose
Wei Li
No relevant relationships to disclose
Fei Zhou
No relevant relationships to disclose
Shuai Li
No relevant relationships to disclose
Caicun Zhou
No relevant relationships to disclose